期刊
JOURNAL OF BLOOD MEDICINE
卷 11, 期 -, 页码 77-80出版社
DOVE MEDICAL PRESS LTD
DOI: 10.2147/JBM.S229526
关键词
atrial fibrillation; obesity; non-vitamin k oral anticoagulant; plasma levels; apixaban; weight loss
类别
We present the case of a 45-year-old man with atrial fibrillation and morbid obesity (weight 128 kg, height 168 cm, BMI 45.4) who was switched from Warfarin 5 mg once daily to Apixaban 5 mg twice daily because he did not achieve at least 60% of the time in therapeutic range. We performed serial determinations of apixaban plasma concentration (at 2, 6, 12, 24 hrs after intake) showing drug levels within reference range, even when the patient lose weight.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据